Literature DB >> 25512506

TSPAN12 is a critical factor for cancer-fibroblast cell contact-mediated cancer invasion.

Ryo Otomo1, Chihiro Otsubo2, Yuko Matsushima-Hibiya3, Makoto Miyazaki4, Fumio Tashiro5, Hitoshi Ichikawa6, Takashi Kohno7, Takahiro Ochiya8, Jun Yokota7, Hitoshi Nakagama9, Yoichi Taya10, Masato Enari11.   

Abstract

Communication between cancer cells and their microenvironment controls cancer progression. Although the tumor suppressor p53 functions in a cell-autonomous manner, it has also recently been shown to function in a non-cell-autonomous fashion. Although functional defects have been reported in p53 in stromal cells surrounding cancer, including mutations in the p53 gene and decreased p53 expression, the role of p53 in stromal cells during cancer progression remains unclear. We herein show that the expression of α-smooth muscle actin (α-SMA), a marker of cancer-associated fibroblasts (CAFs), was increased by the ablation of p53 in lung fibroblasts. CAFs enhanced the invasion and proliferation of lung cancer cells when cocultured with p53-depleted fibroblasts and required contact between cancer and stromal cells. A comprehensive analysis using a DNA chip revealed that tetraspanin 12 (TSPAN12), which belongs to the tetraspanin protein family, was derepressed by p53 knockdown. TSPAN12 knockdown in p53-depleted fibroblasts inhibited cancer cell proliferation and invasion elicited by coculturing with p53-depleted fibroblasts in vitro, and inhibited tumor growth in vivo. It also decreased CXC chemokine ligand 6 (CXCL6) secretion through the β-catenin signaling pathway, suggesting that cancer cell contact with TSPAN12 in fibroblasts transduced β-catenin signaling into fibroblasts, leading to the secretion of CXCL6 to efficiently promote invasion. These results suggest that stroma-derived p53 plays a pivotal role in epithelial cancer progression and that TSPAN12 and CXCL6 are potential targets for lung cancer therapy.

Entities:  

Keywords:  cancer invasion; cancer-associated fibroblasts; cancer–stromal cell interaction; p53; tetraspanin family

Mesh:

Substances:

Year:  2014        PMID: 25512506      PMCID: PMC4284611          DOI: 10.1073/pnas.1412062112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  Sequence and expression of seven new tetraspans.

Authors:  V Serru; P Dessen; C Boucheix; E Rubinstein
Journal:  Biochim Biophys Acta       Date:  2000-03-16

Review 2.  Tetraspanin functions and associated microdomains.

Authors:  Martin E Hemler
Journal:  Nat Rev Mol Cell Biol       Date:  2005-10       Impact factor: 94.444

Review 3.  Fibroblasts in cancer.

Authors:  Raghu Kalluri; Michael Zeisberg
Journal:  Nat Rev Cancer       Date:  2006-05       Impact factor: 60.716

4.  Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas.

Authors:  Keisuke Kurose; Kristie Gilley; Satoshi Matsumoto; Peter H Watson; Xiao-Ping Zhou; Charis Eng
Journal:  Nat Genet       Date:  2002-10-15       Impact factor: 38.330

5.  p53 Attenuates cancer cell migration and invasion through repression of SDF-1/CXCL12 expression in stromal fibroblasts.

Authors:  Neta Moskovits; Alexander Kalinkovich; Jair Bar; Tsvee Lapidot; Moshe Oren
Journal:  Cancer Res       Date:  2006-11-15       Impact factor: 12.701

Review 6.  Friends or foes - bipolar effects of the tumour stroma in cancer.

Authors:  Margareta M Mueller; Norbert E Fusenig
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

7.  Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis.

Authors:  Hippokratis Kiaris; Ioulia Chatzistamou; George Trimis; Matrisa Frangou-Plemmenou; Agatha Pafiti-Kondi; Anastasios Kalofoutis
Journal:  Cancer Res       Date:  2005-03-01       Impact factor: 12.701

8.  TSPAN2 is involved in cell invasion and motility during lung cancer progression.

Authors:  Chihiro Otsubo; Ryo Otomo; Makoto Miyazaki; Yuko Matsushima-Hibiya; Takashi Kohno; Reika Iwakawa; Fumitaka Takeshita; Hirokazu Okayama; Hitoshi Ichikawa; Hideyuki Saya; Tohru Kiyono; Takahiro Ochiya; Fumio Tashiro; Hitoshi Nakagama; Jun Yokota; Masato Enari
Journal:  Cell Rep       Date:  2014-04-13       Impact factor: 9.423

Review 9.  Stromal fibroblasts in cancer initiation and progression.

Authors:  Neil A Bhowmick; Eric G Neilson; Harold L Moses
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

10.  Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium.

Authors:  A F Olumi; G D Grossfeld; S W Hayward; P R Carroll; T D Tlsty; G R Cunha
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

View more
  26 in total

1.  Eosinophilic oesophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study.

Authors:  Tetsuo Shoda; Ting Wen; Seema S Aceves; J Pablo Abonia; Dan Atkins; Peter A Bonis; Julie M Caldwell; Kelley E Capocelli; Christina L Carpenter; Margaret H Collins; Evan S Dellon; Michael D Eby; Nirmala Gonsalves; Sandeep K Gupta; Gary W Falk; Ikuo Hirano; Paul Menard-Katcher; Jonathan T Kuhl; Jeffrey P Krischer; John Leung; Vincent A Mukkada; Jonathan M Spergel; Michael P Trimarchi; Guang-Yu Yang; Nives Zimmermann; Glenn T Furuta; Marc E Rothenberg
Journal:  Lancet Gastroenterol Hepatol       Date:  2018-05-03

Review 2.  The evolving relationship of wound healing and tumor stroma.

Authors:  Deshka S Foster; R Ellen Jones; Ryan C Ransom; Michael T Longaker; Jeffrey A Norton
Journal:  JCI Insight       Date:  2018-09-20

3.  PD-L1 on invasive fibroblasts drives fibrosis in a humanized model of idiopathic pulmonary fibrosis.

Authors:  Yan Geng; Xue Liu; Jiurong Liang; David M Habiel; Vrishika Kulur; Ana Lucia Coelho; Nan Deng; Ting Xie; Yizhou Wang; Ningshan Liu; Guanling Huang; Adrianne Kurkciyan; Zhenqiu Liu; Jie Tang; Cory M Hogaboam; Dianhua Jiang; Paul W Noble
Journal:  JCI Insight       Date:  2019-03-21

4.  Upregulation of TSPAN12 is associated with the colorectal cancer growth and metastasis.

Authors:  Jiao Liu; Chuang Chen; Guang Li; Dechang Chen; Qingshan Zhou
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

5.  TSPAN12 Is a Norrin Co-receptor that Amplifies Frizzled4 Ligand Selectivity and Signaling.

Authors:  Maria B Lai; Chi Zhang; Jianli Shi; Verity Johnson; Lavan Khandan; John McVey; Michael W Klymkowsky; Zhe Chen; Harald J Junge
Journal:  Cell Rep       Date:  2017-06-27       Impact factor: 9.423

Review 6.  Therapy-induced microenvironmental changes in cancer.

Authors:  Yuting Ma; Heng Yang; Jonathan M Pitt; Guido Kroemer; Laurence Zitvogel
Journal:  J Mol Med (Berl)       Date:  2016-03-02       Impact factor: 4.599

7.  miR-196b-5p-mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer.

Authors:  Guang Liang; Wei Meng; Xiangjie Huang; Wangyu Zhu; Changtian Yin; Canwei Wang; Matteo Fassan; Yun Yu; Masahisa Kudo; Sisi Xiao; Chengguang Zhao; Peng Zou; Yumin Wang; Xiaokun Li; Carlo M Croce; Ri Cui
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-10       Impact factor: 11.205

8.  Altered p53 functionality in cancer-associated fibroblasts contributes to their cancer-supporting features.

Authors:  Sharathchandra Arandkar; Noa Furth; Yair Elisha; Nishanth Belugali Nataraj; Heiko van der Kuip; Yosef Yarden; Walter Aulitzky; Igor Ulitsky; Benjamin Geiger; Moshe Oren
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-04       Impact factor: 11.205

Review 9.  Direct Interaction between Carcinoma Cells and Cancer Associated Fibroblasts for the Regulation of Cancer Invasion.

Authors:  Hideki Yamaguchi; Ryuichi Sakai
Journal:  Cancers (Basel)       Date:  2015-10-14       Impact factor: 6.639

Review 10.  Gene aberrations for precision medicine against lung adenocarcinoma.

Authors:  Motonobu Saito; Kouya Shiraishi; Hideo Kunitoh; Seiichi Takenoshita; Jun Yokota; Takashi Kohno
Journal:  Cancer Sci       Date:  2016-05-25       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.